Position in LUNG
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$51,350
-$1,540 QoQ
Shares Held
39,500
-3.7% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#54
of 107 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $25,978,704 across 18 Medical Devices names. LUNG ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BFLY |
Butterfly Network, Inc.
|
867,580 | $7,305,023 | |
| 2 | AXGN |
Axogen, Inc.
|
147,842 | $6,828,821 | |
| 3 | ABT |
Abbott Laboratories
|
20,257 | $1,838,120 | |
| 4 | NEOG |
Neogen Corp
|
177,500 | $1,595,725 | |
| 5 | ATEC |
Alphatec Holdings, Inc.
|
175,197 | $1,515,454 | |
| 6 | LUCD |
Lucid Diagnostics Inc.
|
1,125,000 | $1,203,750 | |
| 7 | TLSI |
TriSalus Life Sciences, Inc.
|
235,101 | $1,069,709 | |
| 8 | TELA |
TELA Bio, Inc.
|
1,375,042 | $1,031,281 |
All Filings in LUNG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,350 | 39,500 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $52,890 | 41,000 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $108,290 | 49,000 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $34,020 | 21,000 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $25,900 | 10,000 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||